Evidence map›Paper›PMID 31307010›Full record

ArticlePsychoneuroendocrinology2019

Allostatic load in the association of depressive symptoms with incident coronary heart disease: The Jackson Heart Study.

Shannon L Gillespie, Cindy M Anderson, Songzhu Zhao, Yubo Tan, David Kline, Guy Brock, James Odei, Emily O'Brien, Mario Sims, Sophie A Lazarus and 3 more

Open access · greenAbstract read
In one paragraph

Article in Psychoneuroendocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 4 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 4 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Allostatic Load and Cardiovascular Disease: A Systematic Review.American journal of preventive medicine · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Affect regulation and allostatic load over time.Psychoneuroendocrinology · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Shannon L GillespieMartha S. Pitzer Center for Women, Children, & Youth, College of Nursing, The Ohio State University, Columbus, OH, United States. Electronic address: gillespie.175@osu.edu.
Cindy M AndersonMartha S. Pitzer Center for Women, Children, & Youth, College of Nursing, The Ohio State University, Columbus, OH, United States.
Songzhu ZhaoDepartment of Bioinformatics, College of Medicine, The Ohio State University, Columbus, OH, United States.
Yubo TanDepartment of Bioinformatics, College of Medicine, The Ohio State University, Columbus, OH, United States.
David KlineDepartment of Bioinformatics, College of Medicine, The Ohio State University, Columbus, OH, United States.
Guy BrockDepartment of Bioinformatics, College of Medicine, The Ohio State University, Columbus, OH, United States.
James OdeiDivision of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH, United States.
Emily O'BrienDuke Clinical Research Institute and Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States.
Mario SimsDepartment of Medicine, University of Mississippi Medical Center, Jackson, MS, United States.
Sophie A LazarusDepartment of Psychology, The Ohio State University, United States.
Darryl B HoodDivision of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, OH, United States.
Karen Patricia WilliamsMartha S. Pitzer Center for Women, Children, & Youth, College of Nursing, The Ohio State University, Columbus, OH, United States.
Joshua J JosephDivision of Endocrinology, Diabetes & Metabolism, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
The Ohio State University · USDuke University · USThe Ohio State University Wexner Medical Center · USUniversity of Mississippi Medical Center · US

Funding

The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve HealthUL1TR002733 · NCATS · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2018 to 2022
$28.9M
The Role of The Renin-Angiotensin-Aldosterone System, ARMC5, and Neprilysin in Glucose Metabolism among African AmericansK23DK117041 · NIDDK · OHIO STATE UNIVERSITY · PI JOSEPH, JOSHUA J · 2018 to 2022
$1.0M
Maternal Immune Responsiveness As CLinical Target for Preterm Birth Prevention (MIRACL)K23NR017902 · NINR · OHIO STATE UNIVERSITY · PI GILLESPIE, SHANNON L. · 2018 to 2020
$477k
NCATS NIH HHS UL1 TR002733NHLBI NIH HHS HHSN268201800010INHLBI NIH HHS HHSN268201800011CNHLBI NIH HHS HHSN268201800011INHLBI NIH HHS HHSN268201800012CNHLBI NIH HHS HHSN268201800012INHLBI NIH HHS HHSN268201800014CNHLBI NIH HHS HHSN268201800014INHLBI NIH HHS HHSN268201800015INIDDK NIH HHS K23 DK117041NIMHD NIH HHS HHSN268201800013ININR NIH HHS K23 NR017902
6 · The paper itself

Abstract

African Americans are at heightened risk for coronary heart disease (CHD), with biologic pathways poorly understood. We examined the role of allostatic load (AL) in the association of depressive symptoms with incident CHD among 2,670 African American men and women in the prospective Jackson Heart Study. Depressive symptoms were quantified using the Center for Epidemiologic Studies Depression Scale (CES-D). Incident CHD was ascertained by self-report, death certificate survey, and adjudicated medical record surveillance. Baseline AL was quantified using biologic parameters of metabolic, cardiovascular, immune, and neuroendocrine subsystems and as a combined meta-factor. Sequential models adjusted for demographic, socioeconomic, and behavioral covariates, stratified to examine differences by sex. Greater depressive symptomatology was associated with greater metabolic, cardiovascular, and immune AL (p-values≤0.036) and AL meta-factor z-scores (p = 0.007), with findings driven by observations among females. Each 1-point increase in baseline depressive symptomatology, and 1-SD increase in metabolic AL, neuroendocrine AL, and AL meta-factor z-scores was associated with 3.3%, 88%, 39%, and 130% increases in CHD risk, respectively (p-values <0.001). Neuroendocrine AL and AL meta-factor scores predicted incident CHD among males but not females in stratified analyses. Metabolic AL partially mediated the association of depressive symptoms with incident CHD (5.79% mediation, p = 0.044), a finding present among females (p = 0.016) but not males (p = 0.840). Among African American adults, we present novel findings of an association between depressive symptomatology and incident CHD, partially mediated by metabolic AL. These findings appear to be unique to females, an important consideration in the design of targeted interventions for CHD prevention.

Indexed as

AdultAgedAllostasisBlack or African AmericanCoronary DiseaseDepressionFemaleHumansIncidenceLongitudinal StudiesMaleMiddle AgedProspective StudiesRisk FactorsSex FactorsWhite PeopleAfrican AmericanAllostatic loadCoronary heart diseaseDepressionMetabolicWomen

Identifiers

PMID31307010
PMCPMC7232849
OpenAlexW2954720645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.